This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Jul 1;65(1):107-109.

doi: 10.1093/cid/cix288.

Definitive Treatment for Methicillin-Susceptible Staphylococcus aureus Bacteremia: Data Versus a Definitive Answer?

Adolf W Karchmer¹

Affiliations

PMID: 28379366
DOI: 10.1093/cid/cix288

Comment

Definitive Treatment for Methicillin-Susceptible Staphylococcus aureus Bacteremia: Data Versus a Definitive Answer?

Adolf W Karchmer. Clin Infect Dis. 2017.

. 2017 Jul 1;65(1):107-109.

doi: 10.1093/cid/cix288.

Author

Adolf W Karchmer¹

Affiliation

¹ Beth Israel Deaconess Medical Center, Division of Infectious Diseases, Harvard Medical School, Boston, Massachusetts.

PMID: 28379366
DOI: 10.1093/cid/cix288

No abstract available

Keywords: S. aureus bacteremia; antistaphylococcal penicillins; cefazolin.

PubMed Disclaimer

Comment on

Comparative Effectiveness of Cefazolin Versus Nafcillin or Oxacillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections Complicated by Bacteremia: A Nationwide Cohort Study.
McDanel JS, Roghmann MC, Perencevich EN, Ohl ME, Goto M, Livorsi DJ, Jones M, Albertson JP, Nair R, O'Shea AMJ, Schweizer ML. McDanel JS, et al. Clin Infect Dis. 2017 Jul 1;65(1):100-106. doi: 10.1093/cid/cix287. Clin Infect Dis. 2017. PMID: 28379314

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations